New program aims to empower women with rheumatoid arthritis
NCT ID NCT06337370
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed trial tested a six-week group self-management program for women with rheumatoid arthritis. The program teaches skills to manage symptoms, stick to treatments, and improve quality of life. Researchers measured changes in self-efficacy, self-management behaviors, and health-related quality of life in 44 women in Bogotá.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Chronic Disease Self-Management Program (CDSMP) - a group education program
- What this could lead to
- If it works, this program could help women with rheumatoid arthritis feel more in control, manage symptoms better, and improve their daily quality of life.
- What could go wrong
- This is a small, early-stage trial with only 44 participants, so results may not apply to everyone. The program is behavioral, not a drug, so benefits may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
44 people
The number who actually took part.
- Started
-
Jun 2024
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * This study examined women over the age of 18 who were treated at rheumatology outpatient clinics at a health center in Bogotá and had a confirmed diagnosis of rheumatoid arthritis according to the 2010 EULAR/ACR classification criteria. Exclusion Criteria: * Women with RA with a comorbid acute process (another or other chronic diseases that the person suffers from and at the time of being identified, are in the exacerbation or crisis phase). * Women with RA who present cognitive impairment that prevents them from participating in the program or answering the questionnaires due to cognitive impossibility to understand them.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Arthritis rheumatoid are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fundación para la Investigación en Dermatología y Reumatología- Funinderma
Bogotá, Bogota D.C., 111311, Colombia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a cementless hip stem hold up in asian patients?
- Immune cell study could pave way for new arthritis treatments
- Are women with autoimmune diseases getting the gynecological care they need?
- Brain scans may predict who gets long-term pain from arthritis
- Can mindfulness ease arthritis pain? small study seeks answers
- Can a simple blood test help rheumatoid arthritis patients get the right drug?